tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Summit Therapeutics falls -24.1%
PremiumThe FlySummit Therapeutics falls -24.1%
15d ago
EchoStar sells spectrum licenses to SpaceX, StubHub to launch IPO: Morning Buzz
Premium
The Fly
EchoStar sells spectrum licenses to SpaceX, StubHub to launch IPO: Morning Buzz
15d ago
Morning Movers: EchoStar jumps following $17B spectrum deal with SpaceX
Premium
The Fly
Morning Movers: EchoStar jumps following $17B spectrum deal with SpaceX
15d ago
Summit Therapeutics announces data from Phase III HARMONi trial
PremiumThe FlySummit Therapeutics announces data from Phase III HARMONi trial
16d ago
Apple upgraded, AMD downgraded: Wall Street’s top analyst calls
Premium
The Fly
Apple upgraded, AMD downgraded: Wall Street’s top analyst calls
19d ago
Guggenheim starts Summit Therapeutics at Buy, sees ‘multi-fold upside potential’
Premium
The Fly
Guggenheim starts Summit Therapeutics at Buy, sees ‘multi-fold upside potential’
19d ago
Summit Therapeutics falls -6.9%
PremiumThe FlySummit Therapeutics falls -6.9%
27d ago
Akeso says ivonescimab met overall survival endpoint in final anlysis
Premium
The Fly
Akeso says ivonescimab met overall survival endpoint in final anlysis
27d ago
Summit Therapeutics price target raised to $50 from $44 at H.C. Wainwright
Premium
The Fly
Summit Therapeutics price target raised to $50 from $44 at H.C. Wainwright
27d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100